TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $791,358 | +198.6% | 94,660 | +111.1% | 0.01% | +33.3% |
| Q3 2022 | $265,000 | -47.9% | 44,841 | +193.1% | 0.01% | -25.0% |
| Q3 2021 | $509,000 | -33.8% | 15,300 | -22.8% | 0.01% | -46.7% |
| Q2 2021 | $769,000 | -7.5% | 19,824 | +24.0% | 0.02% | -34.8% |
| Q4 2020 | $831,000 | +422.6% | 15,983 | -1.1% | 0.02% | +64.3% |
| Q1 2020 | $159,000 | -42.2% | 16,160 | -52.7% | 0.01% | +27.3% |
| Q1 2019 | $275,000 | +30.3% | 34,196 | +91.6% | 0.01% | +120.0% |
| Q3 2017 | $211,000 | +47.6% | 17,848 | -24.1% | 0.01% | +66.7% |
| Q2 2016 | $143,000 | – | 23,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |